We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GLXG:NASDAQGalaxy Payroll Group Limited Analysis

Data as of 2026-04-06 - not real-time

$2.25

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Galaxy Payroll’s stock is trading just above its 20‑day SMA (≈$2.24) while the 20‑day SMA sits modestly above the 50‑day SMA (≈$2.15), suggesting a very thin short‑term bias that is quickly eroded by a bearish MACD histogram and an RSI hovering at 49.7, indicating no clear momentum. Volume is increasing, yet the 30‑day volatility is extreme at roughly 94%, beta is negative (‑0.84) and the historical max drawdown exceeds 80%, underscoring a highly unstable price profile. Fundamental metrics are equally concerning: operating margins are deeply negative (‑144%), cash flow from operations is a drain (≈‑$27.7 M), and the company carries a modest debt load but a debt‑to‑equity ratio above 4, while the price‑to‑book sits at 1.4 and the price‑to‑sales at 0.49, hinting at a discount relative to book value but no earnings support.
The recent renewal of a five‑year strategic cooperation with NIKE China could provide a catalyst for top‑line growth, yet the firm’s earnings per share remain deeply negative (‑$19.48) and there is no dividend history, making the stock a pure speculative play. With a market cap of only $13.4 M and thin daily volumes, liquidity risk is pronounced, and the extreme‑greed market sentiment does not offset the structural weakness. Consequently, the stock appears undervalued from a pure price‑to‑book perspective but carries substantial downside risk, warranting a cautious stance.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram
  • Negative operating and profit margins
  • Extreme short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strategic partnership with NIKE China
  • Low price‑to‑book relative to assets
  • Continued cash‑flow deficits

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Potential turnaround if top‑line growth materializes
  • High max drawdown and beta indicating market sensitivity
  • Absence of dividend and earnings generation

Key Metrics & Analysis

Financial Health

Revenue Growth-9.30%
Profit Margin-100.51%
ROE-164.22%
ROA-52.80%
Debt/Equity4.57
P/B Ratio1.4
Op. Cash Flow$-27707982
Free Cash Flow$-23402752
Industry P/E28.9

Technical Analysis

TrendNeutral
RSI49.7
Support$1.90
Resistance$2.84
MA 20$2.24
MA 50$2.15
MA 200$3.83
MACDBearish
VolumeIncreasing
Fear & Greed Index78.8

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta-0.84
Volatility94.44%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.